GeneQuine Biotherapeutics became second in the Science Startup of the Year competition at the prestigious Falling Walls conference in Berlin.

GeneQuine was nominated by its investors the High-Tech Gründerfonds to present at the Falling Walls Venture conference along with 27 other international startups. GeneQuine was selected as one of the three finalists and was voted second by a distinguished jury of international industry leaders, strategy consultants and venture capitalists.